China SXT Pharmaceuticals Files Prospectus Supplement
Ticker: SXTC · Form: 424B5 · Filed: 2026-04-09T09:00:41-04:00
Sentiment: neutral
Topics: prospectus-supplement, filing, pharmaceuticals
TL;DR
China SXT Pharma filed a 424B5 prospectus supplement on 4/9/26. Watch for potential stock activity.
AI Summary
China SXT Pharmaceuticals, Inc. filed a 424B5 form on April 9, 2026, related to a prospectus supplement. The filing details their business operations and corporate information, including their mailing and business addresses in Taizhou, China, and their CIK number 0001723980.
Why It Matters
This filing indicates a potential offering or update to existing securities, which could impact the company's capital structure and future operations.
Risk Assessment
Risk Level: medium — Prospectus supplements often precede stock offerings or significant corporate actions that can introduce volatility.
Key Numbers
- 0001723980 — CIK Number (Unique identifier for China SXT Pharmaceuticals, Inc.)
- 2026-04-09 — Filing Date (Date the 424B5 form was accepted by the SEC.)
Key Players & Entities
- China SXT Pharmaceuticals, Inc. (company) — Filer of the 424B5 form
- 0001723980 (company) — CIK number for China SXT Pharmaceuticals, Inc.
- 2026-04-09 (date) — Filing date of the 424B5 form
- Taizhou, China (location) — Location of the company's mailing and business addresses
FAQ
What is the purpose of a 424B5 filing?
A 424B5 filing is a prospectus supplement used to provide additional information or updates to an already filed registration statement, often related to the offering of securities.
When was this specific 424B5 filing made by China SXT Pharmaceuticals, Inc.?
The filing date was April 9, 2026.
What is the CIK number for China SXT Pharmaceuticals, Inc.?
The CIK number for China SXT Pharmaceuticals, Inc. is 0001723980.
Where are China SXT Pharmaceuticals, Inc.'s business and mailing addresses located?
Both the mailing and business addresses are located at 178 Taidong Road North, Taizhou, China.
What is the SIC code for China SXT Pharmaceuticals, Inc.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
From the Filing
EDGAR Filing Documents for 0001213900-26-041766 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 424B5 - Prospectus [Rule 424(b)(5)]: SEC Accession No. 0001213900-26-041766 Filing Date 2026-04-09 Accepted 2026-04-09 09:00:41 Documents 3 Document Format Files Seq Description Document Type Size 1 PROSPECTUS SUPPLEMENT ea0285552-424b5_chinasxt.htm 424B5 295341 2 GRAPHIC ea028555202_img1.jpg GRAPHIC 8592 3 GRAPHIC ea028555202_img2.jpg GRAPHIC 8592 Complete submission text file 0001213900-26-041766.txt 320370 Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU China Business Address 178 TAIDONG ROAD NORTH TAIZHOU China 8652386298290 China SXT Pharmaceuticals, Inc. (Filer) CIK : 0001723980 (see all company filings) EIN. : 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331 Type: 424B5 | Act: 33 | File No.: 333-291428 | Film No.: 26849963 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)